How to manage hypercholesterolemia and hypertriglyceridemia in a patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Hypercholesterolemia and Hypertriglyceridemia

Initial Assessment

This 53-year-old woman with total cholesterol 249 mg/dL and triglycerides 150 mg/dL has mild hypertriglyceridemia and borderline high cholesterol that requires aggressive lifestyle modification as first-line therapy, with statin consideration based on her 10-year ASCVD risk calculation. 1

Before initiating any pharmacotherapy, you must evaluate for secondary causes including:

  • Uncontrolled diabetes or prediabetes (check HbA1c and fasting glucose) 1, 2
  • Hypothyroidism (check TSH) 1, 2
  • Excessive alcohol intake (detailed quantitative history) 3, 1
  • Medications that raise lipids (thiazide diuretics, beta-blockers, estrogen therapy, corticosteroids) 1
  • Renal disease (check creatinine and urinalysis) 1

Calculate her 10-year ASCVD risk using the pooled cohort equations to determine if statin therapy is indicated. 2

Lifestyle Modifications (Mandatory First-Line Therapy)

Weight Management

  • Target 5-10% body weight reduction, which produces a 20% decrease in triglycerides and can reduce levels by up to 50-70% in some patients. 1, 2
  • Weight loss of 1 kg reduces triglycerides by approximately 1.5-1.9 mg/dL. 1

Dietary Interventions

  • Restrict added sugars to <6% of total daily calories and eliminate all sugar-sweetened beverages completely, as sugar intake directly increases hepatic triglyceride production. 3, 1, 2
  • Limit total fat to 30-35% of total daily calories for mild-moderate hypertriglyceridemia. 3, 1, 2
  • Restrict saturated fats to <7% of total calories, replacing with polyunsaturated or monounsaturated fats. 1
  • Eliminate trans fatty acids completely. 1
  • Increase soluble fiber to >10 g/day from sources like oats, beans, and vegetables. 3, 1
  • Consume ≥2 servings (8+ ounces) per week of fatty fish (salmon, trout, sardines, anchovies) rich in EPA and DHA. 1
  • Replace refined carbohydrates with fiber-rich whole grains, as low-carbohydrate diets are more effective than low-fat diets for reducing triglycerides. 1, 4

Alcohol Restriction

  • Limit alcohol to no more than 1 standard drink per day (12 oz beer, 5 oz wine, or 1.5 oz spirits), as even 1 ounce daily increases triglycerides by 5-10%. 3, 1, 2
  • Alcohol effects are synergistically exaggerated when coupled with meals high in saturated fat. 3

Physical Activity

  • Engage in at least 150 minutes per week of moderate-intensity aerobic activity (or 75 minutes per week of vigorous activity), which reduces triglycerides by approximately 11%. 3, 1, 2
  • Regular aerobic training is superior to resistance training for triglyceride reduction (11% vs 6% reduction). 3

Pharmacologic Therapy Algorithm

If 10-Year ASCVD Risk ≥7.5%

Initiate moderate-intensity statin therapy (atorvastatin 10-20 mg or rosuvastatin 5-10 mg daily) as the primary pharmacologic intervention, which provides 10-30% dose-dependent triglyceride reduction and proven cardiovascular risk reduction. 1, 2

If 10-Year ASCVD Risk 5% to <7.5%

Engage in patient-clinician discussion regarding statin initiation, as persistently elevated triglycerides ≥150 mg/dL constitute a cardiovascular risk-enhancing factor that may favor treatment. 1, 2

If 10-Year ASCVD Risk <5%

Focus exclusively on intensive lifestyle modifications for 3-6 months before considering pharmacotherapy. 1, 2

Monitoring and Follow-Up

  • Reassess fasting lipid panel in 6-12 weeks after implementing lifestyle modifications. 1, 2
  • If statin therapy is initiated, recheck lipids 4-8 weeks after starting or adjusting medication. 1
  • Calculate non-HDL cholesterol (total cholesterol minus HDL cholesterol) with a target goal of <130 mg/dL if triglycerides remain 150-199 mg/dL. 1, 2

Critical Pitfalls to Avoid

  • Do not initiate pharmacotherapy without first addressing secondary causes, particularly uncontrolled diabetes or hypothyroidism, as treating these conditions can dramatically reduce lipid levels independent of lipid medications. 1, 5
  • Do not use bile acid sequestrants if triglycerides are >200 mg/dL, as they are relatively contraindicated and can worsen hypertriglyceridemia. 1
  • Do not substitute over-the-counter fish oil supplements for prescription omega-3 formulations if pharmacotherapy becomes necessary, as they are not equivalent. 1

When to Intensify Therapy

If after 3 months of optimized lifestyle modifications and statin therapy (if indicated), triglycerides remain >200 mg/dL, consider adding prescription omega-3 fatty acids (icosapent ethyl 2-4 g/day), particularly if the patient has established cardiovascular disease or diabetes with ≥2 additional risk factors. 1, 2

References

Guideline

Hypertriglyceridemia Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Moderate Hypertriglyceridemia in Adults with ASCVD Risk

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Manejo de la Hipertrigliceridemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

2024 KSoLA Consensus on Secondary Dyslipidemia.

Journal of lipid and atherosclerosis, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.